Hormone therapy cluster
Hormone Therapy in Women With Migraine
Migraine affects roughly one in five women, so this situation is common rather than exotic. It calls for a considered prescription — not an automatic refusal, and not a casual one either.
Medically Reviewed
Medically reviewed by Amarish Dave, DO
Board-Certified Neurologist
Last medically reviewed: September 10, 2026
Can women with migraine use menopausal hormone therapy?
Yes, in general — migraine is not by itself a contraindication. What migraine does is add specific considerations: aura status, vascular risk profile, and a preference for regimens that keep hormone levels steady.
The confusion usually comes from contraception. Combined hormonal contraceptives use much higher estrogen doses and are generally avoided in migraine with aura. Menopausal hormone therapy is a different dose range and is assessed separately.
What does aura change about the decision?
It raises the priority of vascular risk management and favours the lowest effective dose delivered by a non-oral route. It is a reason for a careful, individualized decision — not a blanket prohibition.
- Stop smoking: this is the single most valuable action alongside aura
- Get blood pressure, lipids and glucose measured and treated
- Prefer transdermal estrogen at the lowest effective dose
- Prefer continuous over cyclical regimens where appropriate
- Review the decision periodically rather than treating it as permanent
How should headache be monitored on treatment?
With a simple diary of headache days, severity, aura episodes and acute medication use, started before treatment begins and continued for a few months afterwards. Without a baseline, it is impossible to tell whether anything actually changed.
Record acute medication days honestly. Medication-overuse headache is a frequent and treatable reason for a picture that appears to be worsening on hormone therapy when the two are unrelated.
When should treatment be reassessed urgently?
If aura is new for you, if aura lasts longer than about an hour, if you develop weakness, numbness or speech difficulty, or if you develop calf pain, swelling or unexplained breathlessness — these need prompt medical attention rather than a wait-and-see approach.
For sudden one-sided weakness, sudden speech difficulty, sudden vision loss or a sudden extremely severe headache, call emergency services. That advice does not change because you are on hormone therapy — it becomes more important.
When should I talk to a clinician?
Bring these to the prescribing appointment:
- Whether you have ever had aura, and what it looked like
- A recent headache diary with acute medication days
- Your blood pressure, smoking status and vascular history
- Which menopausal symptoms are bothering you most
- A plan for reviewing the decision in a few months
- Migraine alone does not rule out hormone therapy.
- Contraceptive rules about aura do not transfer directly.
- Aura raises the priority of vascular risk management.
- Steady, low-dose, non-oral regimens are generally preferred.
- Keep a headache diary before and after starting.
- New or prolonged aura needs prompt reassessment.
Educational assessment
The Menopause Brain Health Check organizes your symptoms and modifiable factors into patterns you can bring to an appointment. It is private, needs no account, and does not diagnose anything.
Questions
Common questions
Is hormone therapy safe for women with migraine?
Migraine is not an automatic contraindication to menopausal hormone therapy. The decision is individualized: aura status, vascular risk factors, blood pressure, smoking, and which menopausal symptoms need treating all shape the choice of route, dose and regimen.
Which regimen is usually preferred with migraine?
Clinically, steadier delivery is generally favoured — a low-dose transdermal estrogen in a continuous rather than cyclical regimen — because migraine responds to hormonal fluctuation. Progestogen type and schedule are also considered, since they affect sleep and mood.
What if my migraines get worse after starting?
Tell the prescriber rather than simply stopping. Adjusting the route, lowering the dose or moving from a cyclical to a continuous regimen often helps. New aura, or aura lasting more than an hour, should prompt prompt reassessment.
Share this page
Send this page to someone who may find it helpful.
Menopause changes more than hormones.
Follow the science of menopause, brain fog, sleep, migraine and long-term brain health with The MenoCortex Brief.
References & further reading
- 1.The Menopause Society — position statements and clinical guidance — The Menopause Society
- 2.Position statements and clinical guidance on migraine care — American Headache Society
- 3.Stroke risk factors and prevention guidance — American Heart Association / American Stroke Association
- 4.Patient guidance on perimenopause, menopause and hormone therapy — American College of Obstetricians and Gynecologists